Tissue distribution of the opioid receptor-like (ORL1) receptor

被引:200
|
作者
Mollereau, C [1 ]
Mouledous, L [1 ]
机构
[1] Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
关键词
neuropeptide; nociceptin or orphanin FQ; ORL1; receptor; G protein-coupled receptor; anatomic distribution;
D O I
10.1016/S0196-9781(00)00227-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ORL1 receptor is a G protein-coupled receptor structurally related to the opioid receptors, whose endogenous ligand is the heptadecapeptide nociceptin/orphanin FQ. In this review, data which have contributed to the mapping of the anatomic distribution of the ORL1 receptor have been collated with an emphasis on their relation to physiological functions. The ORL1 receptor is widely expressed in the central nervous system, in particular in the forebrain (cortical areas, olfactory regions, limbic structures, thalamus), throughout the brainstem (central periaqueductal gray, substantia nigra, several sensory and motor nuclei), and in both the dorsal and ventral horns of the spinal cord. Regions almost devoid of ORL1 receptors are the caudate-putamen and the cerebellum ORL1 mRNA and binding sites exhibit approximately the same distribution pattern, indicating that the ORL1 receptor is located on local neuronal circuits. The ORL1 receptor is also expressed at the periphery in smooth muscles, peripheral ganglia, and the immune system. The anatomic distribution of ORL1 receptor suggests a broad spectrum of action for the nociceptin/orphanin FQ system (sensory perception, memory process, emotional behavior, etc.). (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:907 / 917
页数:11
相关论文
共 50 条
  • [41] The stereoselective κ-opioid receptor antagonist Mr2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor
    Bauer, U
    Nakazi, M
    Kathmann, M
    Göthert, M
    Schlicker, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 359 (01) : 17 - 20
  • [42] Opioid receptor-like antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (04) : 164 - 164
  • [43] The ORL1 receptor:: Molecular pharmacology and signalling mechanisms
    New, DC
    Wong, YH
    NEUROSIGNALS, 2002, 11 (04) : 197 - 212
  • [44] Antinociceptive effects of ORL1 receptor agonists in monkeys
    Ko, MCH
    FASEB JOURNAL, 2004, 18 (05): : A961 - A961
  • [45] Modelling of ORL1 receptor-ligand interactions
    Milan Senćanski
    Milovan D. Ivanović
    Ljiljana Došen-Mićović
    Chemical Papers, 2014, 68 : 1305 - 1316
  • [46] Nociceptin and the ORL1 receptor: Pharmacology of a new opioid receptor [Nociceptin und der ORL1-rezeptor: Pharmakologie eines neuen opioidrezeptors]
    Grond S.
    Meuser T.
    Pietruck C.
    Sablotzki A.
    Der Anaesthesist, 2002, 51 (12) : 996 - 1005
  • [47] Opioid like (ORL-1) receptor in septic patients
    Stamer, UM
    Shu, Q
    Stuber, F
    CRITICAL CARE MEDICINE, 2000, 28 (12) : A56 - A56
  • [48] The Orphanin FQ (ORL1) Receptor: Expression of a Novel Opioid-Like Receptor in the Central Nervous System of the Developing Rat and Human Brain
    C R Neal
    H Akil
    S J Watson
    Pediatric Research, 1999, 45 : 345 - 345
  • [49] The orphanin FQ (ORL1) receptor: Expression of a novel opioid-like receptor in the central nervous system of the developing rat and human brain
    Neal, CR
    Akil, H
    Watson, SJ
    PEDIATRIC RESEARCH, 1999, 45 (04) : 345A - 345A
  • [50] Characterisation of the ORL1 receptor on adrenergic nerves in the anococcygeus
    Ho, M
    Watson, A
    Corbett, AD
    McKnight, AT
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 : U47 - U47